We have reported that
interleukin-1 beta (IL-1 beta) upregulates cardiac expression of
vascular endothelial growth factor (
VEGF) and
VEGF receptor-2 (VEGFR-2), raising the possibility that
IL-1 beta plays an important role in
VEGF-mediated neovascularization. In this study, we examined the cellular mechanism for
ischemia-induced neovascularization using
IL-1 beta knock-out (-/-) mice. Recovery of blood perfusion in ischemic hindlimb in
IL-1 beta-/- mice was markedly (43% decrease) impaired as compared with the wild-type mice. CD31(+) vessel numbers and Ki-67(+) neo-capillaries were significantly (P < 0.01) decreased 44% and 68%, respectively.
IL-1 beta expression was localized in the capillary vessels in ischemic limb muscles.
Ischemia-induced expressions of
hypoxia-inducible factor 1 alpha (HIF-1 alpha),
VEGF, its receptor
VEGFR-2 and
vascular cell adhesion molecule-1 (VCAM-1) were markedly inhibited in the
IL-1 beta-/- mice. Hindlimb
ischemia-induced an increase (1.22% out of total nuclear cell) in CD34(-)/B220(-)/CD3(-)/Flk-1(+) hematopoietic stem cell population in peripheral blood in the wild-type mice, whereas in the
IL-1 beta-/- mice such increase was only 0.09%. Injection of
IL-1 beta protein into the wild-type mice markedly increased the ratio of the CD34(-)/B220(-)/CD3(-)/Flk-1(+) cell population (from 0.03% to 0.7%) in the peripheral blood associated with an increase in the number of endothelial cells. Such
IL-1 beta-mediated increases in cell numbers were blocked by co-injection of anti-
VEGF antibody. CD34(-)/B220(-)CD3(-)Flk-1(+) cells trans-differentiated into eNOS- and CD31-expressing endothelial cells in vivo and in vitro. This study demonstrates that
IL-1 beta plays a key role in
ischemia-induced neovascularization by mobilizing CD34(-)/B220(-)CD3(-)Flk-1(+) endothelial precursor cells in a
VEGF-dependent manner as well as by upregulating expressions of
VEGF,
VEGFR-2 and adhesion molecules on endothelial cells.